Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Butamben. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 0.87 |
| ▸ | RAB9A | P51151 | 2/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.87 |
| ▸ | MAPT | P10636 | 1/20 | 0.87 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.77 |
| ▸ | SCN1A | P35498 | 2/20 | 0.77 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.77 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.77 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.77 |
| ▸ | HTR1A | P08908 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.77 |
| ▸ | DRD3 | P35462 | 1/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butamben SCHEMBL27614630 | 0.98 | LMNA (0.97) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| Butamben SCHEMBL28512544 | 0.98 | LMNA (0.97) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| Butamben SCHEMBL9561560 | 0.95 | LMNA (0.90) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL769120 | 0.95 | ALDH1A1 (0.97) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL25012972 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL204048 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL1265838 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL1265146 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL3320139 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 | |
| SCHEMBL9068530 | 0.93 | ALDH1A1 (1.00) | LMNACYP1A2CYP3A4TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4802 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-28 | — | — | US | claimed |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4694866-A1 | SUSTAINED RELEASE STABLE EMULSION PHARMACEUTICAL FORMULATIONS | Insitu Biologics, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4436552-B1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B V (NL) | 2026-02-04 | — | — | EP | claimed |
| US-20260007753-A1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-12419959-B2 | Dermal skin protectant and carrier | Inspired Material Strategies, LLC (US) | 2025-09-23 | — | — | US | claimed |
| US-20250285560-A1 | AR MARKER FOR INJECTION | NOBLE INTERNATIONAL, LLC | 2025-09-11 | — | — | US | claimed |
| EP-3876904-B1 | ORAL MUCOSAL CARRIER AND PROTECTANT | INSPIRED MAT STRATEGIES LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3876949-B1 | DERMAL SKIN PROTECTANT AND CARRIER | INSPIRED MAT STRATEGIES LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-0512547-A1 | Pain controlling composition and method of preparation | Shulman, Morton (US) | 1992-11-11 | — | — | EP | claimed |
| EP-0502119-A1 | LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES. | NOVA PHARM CORP (US) | 1992-09-09 | — | — | EP | claimed |
| WO-1991007171-A1 | LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES | NOVA PHARMACEUTICAL CORPORATION (US) | 1991-05-30 | — | — | WO | claimed |
| EP-0197308-B1 | COMPOSITION AND METHOD FOR PRODUCING PROLONGED PAIN RELIEF | Shulman, Morton (US) | 1991-04-10 | — | — | EP | claimed |
| US-5002974-A | Oil phase with nonionic surfactant, water phase with thickener for emulsions for skin | WARNER-LAMBERT CO. (US) | 1991-03-26 | — | — | US | claimed |
| EP-0383481-A2 | Anesthetic oral compositions | Richardson-Vicks, Inc. (US) | 1990-08-22 | — | — | EP | claimed |
| EP-0336901-A2 | Anesthetic skin moisturizing composition and method of preparing same | WARNER-LAMBERT COMPANY (US) | 1989-10-11 | — | — | EP | claimed |
| EP-0197308-A2 | Composition and method for producing prolonged pain relief | Shulman, Morton (US) | 1986-10-15 | — | — | EP | claimed |
| US-4599354-A | Composition and method for producing prolonged pain relief | LB 1 GROUP INC. | 1986-07-08 | — | — | US | claimed |
| US-4495174-A | TIME-RELEASE AGENTS | RESEARCH CORPORATION (US) | 1985-01-22 | — | — | US | claimed |